Daturametelin I has shown potential in neurological research due to its interaction with cholinergic systems. It is studied for its cognitive-enhancing and neuroprotective properties, particularly in models of neurodegenerative diseases such as Alzheimer's. The compound exhibits acetylcholinesterase inhibitory activity, which helps increase acetylcholine levels in the brain, supporting memory and learning functions. It is also being explored for its anti-inflammatory effects in neural tissues, suggesting possible therapeutic applications in managing neuroinflammation. Due to its natural origin and specific activity, it serves as a lead compound in developing novel treatments for cognitive disorders.